Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft-tissue sarcoma: a meta-analysis and clinical practice guideline.
about
Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcomaTreatment of Adult Soft Tissue Sarcomas: An OverviewDose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline.Efficacy and safety of gemcitabine plus docetaxel in Japanese patients with unresectable or recurrent bone and soft tissue sarcoma: Results from a single-institutional analysisVEGF blockade decreases the tumor uptake of systemic oncolytic herpes virus but enhances therapeutic efficacy when given after virotherapy.Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.Dose-intensive chemotherapy in advanced adult soft tissue sarcoma.Transarterial chemoembolization in soft-tissue sarcoma metastases to the liver - the use of imaging biomarkers as predictors of patient survivalManagement of soft tissue sarcomas of the extremities.Efficacy of phosphatidylinositol-3 kinase inhibitors in a primary mouse model of undifferentiated pleomorphic sarcoma.Systemic therapy for advanced soft tissue sarcomas: highlighting novel therapies and treatment approachesStable expression of promyelocytic leukaemia (PML) protein in telomerase positive MCF7 cells results in alternative lengthening of telomeres phenotypeNew drugs and combinations for the treatment of soft-tissue sarcoma: a review.Management of advanced adult soft tissue sarcoma.Adult human sarcomas. II. Medical oncology.Cardiac systolic dysfunction in doxorubicin-challenged rats is associated with upregulation of MuRF2 and MuRF3 E3 ligasesPhase III Soft Tissue Sarcoma Trials: Success or Failure?Clinical and pharmacokinetic evaluation of trabectedin for the treatment of soft-tissue sarcoma.Clinical trial end points for assessing efficacy of novel therapies for soft-tissue sarcomas.Novel systemic therapies in advanced liposarcoma: a review of recent clinical trial resultsSystemic treatment of soft-tissue sarcoma-gold standard and novel therapies.Histology-Driven Therapy: The Importance of Diagnostic Accuracy in Guiding Systemic Therapy of Soft Tissue Tumors.Metastatic secondary fibrosarcoma of bone responsive to repeated courses of Ifosfamide and associated with hypoglycemia.Synovial Sarcoma: Advances in Diagnosis and Treatment Identification of New Biologic Targets to Improve Multimodal Therapy.Olaratumab for soft tissue sarcoma.Trabectedin for sarcomas in daily clinical practice: analysis of 45 patients treated in a French institution.Consolidation with high-dose chemotherapy and stem cell support for responding patients with metastatic soft tissue sarcomas: prospective, single-institutional phase II study.A retrospective cohort study of treatment patterns among patients with metastatic soft tissue sarcoma in the US.Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents.Feasibility and clinical value of CT-guided (125)I brachytherapy for metastatic soft tissue sarcoma after first-line chemotherapy failure.In vitro effects of perifosine, bortezomib and lenalidomide against hematopoietic progenitor cells from healthy donors.Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma.Developments in the management of advanced soft-tissue sarcoma - olaratumab in context.Primary hepatic carcinosarcoma with multimodal treatment
P2860
Q24247966-7D9B25B6-D0A5-44E8-9531-A09D8EFC5237Q28088685-DDC9478C-88AB-4ED3-8EF6-F1F869848DD5Q33379481-9326F6E8-9FA5-4493-872A-11DEFB609A11Q33657779-1116BE0A-9A71-4E9C-8095-32D19539C526Q33976318-26DF0202-DECC-4AB3-9679-F6A1B5DB0FA1Q34046989-9CF578E2-948A-4F63-9559-70B22E311D0EQ34734533-EEFA7B61-CAD2-49A9-A280-93515D183E5CQ35044274-607BD798-6EC7-47EC-BB69-F81E29C4D9D0Q35728710-080E0512-A9AB-4C34-A184-1FEACA66AD56Q35955302-7F03E114-65C1-4D32-B218-6CC28FFA0399Q36144210-ACBD56C0-180B-4A81-B737-335BB47EAAEAQ36249103-D0EDF455-9C84-4AE8-9985-C5C463C9ABA0Q36444369-C13660D9-6245-43CD-A2C1-1C9C236E2974Q36674228-24F15D83-A6E8-42DF-9D1A-40984F0BD6A9Q36731430-8D6BCACF-F82D-4C94-B20B-78F1842A00D6Q36772298-B243D86E-7BC5-425C-BAD5-1E1E867FEE6EQ37716872-A08BAE2F-806D-4734-849E-CBE0B3B30DF7Q37969213-11BE65B4-7D8C-4967-B009-793EC272102BQ38055499-FB7BB1A6-7CDC-4E39-88C7-E0FCB31D50DBQ38161734-6684E6AC-1CB7-472F-A164-B576F8DC6A2CQ38197031-96EA0741-7831-470C-A039-75FEF9B616C0Q38591828-7F66A66D-8E8B-46D7-A9BB-B5B1C88EA136Q38613398-503EEA02-CDFC-4133-82DF-B5B799CC82ECQ39233440-66F1B98C-0950-43CE-8AED-7E44A26981B9Q39425301-64C9D691-D092-47B3-BA04-24B5A7830ED8Q39480148-7F9D6073-4252-45B0-A64D-FAA28CCFAA7CQ43236387-024A590B-B827-45CF-BFD1-B2920472DE7FQ45983851-EB473988-FAE7-4532-B566-8BAD2DF61B4DQ47239615-A348DA3E-43A6-4895-B3C1-F5B238F062F0Q49691413-65336B18-24F7-49B9-B66D-5AACB855C455Q50436837-817B41EB-EFC1-44D8-890F-38C9AF24F9E6Q51285275-CF1BA18D-8C4A-42FC-B574-4F55DB05EDC4Q52678077-0EA83026-927B-45DC-9681-F3E083AED094Q58804710-C5E504AF-9113-4499-90A4-2A99B55FCE0E
P2860
Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft-tissue sarcoma: a meta-analysis and clinical practice guideline.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Doxorubicin-based chemotherapy ...... d clinical practice guideline.
@ast
Doxorubicin-based chemotherapy ...... d clinical practice guideline.
@en
type
label
Doxorubicin-based chemotherapy ...... d clinical practice guideline.
@ast
Doxorubicin-based chemotherapy ...... d clinical practice guideline.
@en
prefLabel
Doxorubicin-based chemotherapy ...... d clinical practice guideline.
@ast
Doxorubicin-based chemotherapy ...... d clinical practice guideline.
@en
P2093
P2860
P1433
P1476
Doxorubicin-based chemotherapy ...... d clinical practice guideline.
@en
P2093
D Anderson
M L Charette
V H Bramwell
P2860
P304
P356
10.1080/13577140020008066
P577
2000-01-01T00:00:00Z